CureVac N.V.
CVAC
$5.40
$0.000.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 50.37% | -99.65% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 50.37% | -99.65% | |||
| Cost of Revenue | 172.64% | -92.56% | |||
| Gross Profit | -5,906.88% | -99.99% | |||
| SG&A Expenses | 65.32% | -7.12% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -203.71% | 91.91% | |||
| Total Operating Expenses | 22.14% | -26.91% | |||
| Operating Income | -21.68% | -130.17% | |||
| Income Before Tax | -25.20% | -130.72% | |||
| Income Tax Expenses | -202.06% | -96.83% | |||
| Earnings from Continuing Operations | -23.33% | -133.69% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -23.33% | -133.69% | |||
| EBIT | -21.68% | -130.17% | |||
| EBITDA | -23.31% | -127.44% | |||
| EPS Basic | -23.34% | -133.58% | |||
| Normalized Basic EPS | -25.18% | -127.82% | |||
| EPS Diluted | -23.34% | -133.65% | |||
| Normalized Diluted EPS | -21.34% | -127.82% | |||
| Average Basic Shares Outstanding | 0.01% | 0.31% | |||
| Average Diluted Shares Outstanding | 3.20% | 0.31% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||